EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS
· Delayed Price · Currency is USD
311.06
+6.08 (1.99%)
Aug 15, 2025, 3:42 PM EDT
ESLOF Revenue
EssilorLuxottica Société anonyme had revenue of 14.02B EUR in the half year ending June 30, 2025, with 9.13% growth. This brings the company's revenue in the last twelve months to 27.24B, up 5.45% year-over-year. In the year 2024, EssilorLuxottica Société anonyme had annual revenue of 26.51B with 4.38% growth.
Revenue (ttm)
27.24B EUR
Revenue Growth
+5.45%
P/S Ratio
4.51
Revenue / Employee
177.47K EUR
Employees
153,498
Market Cap
144.45B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.51B | 1.11B | 4.38% |
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| BioStem Technologies | 332.45M |
EssilorLuxottica Société anonyme News
- 12 days ago - EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing - GlobeNewsWire
- 17 days ago - EssilorLuxottica: Publication of the 2025 Interim Financial Report - GlobeNewsWire
- 17 days ago - Essilor Luxottica earnings boost illustrates growth potential for Meta’s smartglasses - MarketWatch
- 17 days ago - EssilorLuxottica Touts Growth Potential of Smart Glasses - The Wall Street Journal
- 17 days ago - EssilorLuxottica gives H1 results - Seeking Alpha
- 18 days ago - Ray-Ban Meta smart glasses revenue tripled over the year, EssilorLuxottica says - CNBC
- 18 days ago - EssilorLuxottica (ESLOF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - EssilorLuxottica 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha